Title: The Innovations of Wen-liang Chang
Introduction: Wen-liang Chang is an inventor based in Taipei City, Taiwan. He is currently associated with Sinphar Tian-li Pharmaceutical Co., Ltd. Although he has not yet been granted any patents, his work in pharmaceutical innovations is noteworthy. His research focuses on developing compounds that could lead to effective anti-influenza drugs.
Latest Patent Applications: One of his significant patent applications is titled "4,5-Diamino-3-Halo-2-Hydroxybenzoic Acid Derivatives and Preparations Thereof." This application discloses various derivatives of 4,5-diamino-3-halo-2-hydroxybenzoic acid and their potential uses. The derivatives are presented by a specific formula, where Rgroup can be H, CH, or CH, and other variations. The compounds have shown to be non-toxic to MDCK cells, with certain compounds demonstrating better anti-H1N1 activity. The future potential of these compounds lies in targeting viral neuraminidases to develop effective anti-influenza drugs.
Conclusion: Wen-liang Chang's contributions to pharmaceutical research, particularly in the area of anti-influenza drug development, highlight his innovative spirit and dedication to advancing medical science. His ongoing work may lead to significant breakthroughs in the treatment of viral infections.